Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 1
1991 5
1992 5
1993 12
1994 6
1995 3
1996 1
1997 2
1998 1
1999 3
2000 3
2001 3
2002 2
2003 2
2004 5
2006 3
2007 9
2008 9
2009 4
2010 1
2011 6
2012 12
2013 16
2014 16
2015 21
2016 23
2017 19
2018 17
2019 17
2020 13
2021 16
2022 20
2023 10
2024 11
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, Nair G, Nakabiito C, Nuwagaba-Biribonwoha H, Panchia R, Singh N, Siziba B, Farrior J, Rose S, Anderson PL, Eshleman SH, Marzinke MA, Hendrix CW, Beigel-Orme S, Hosek S, Tolley E, Sista N, Adeyeye A, Rooney JF, Rinehart A, Spreen WR, Smith K, Hanscom B, Cohen MS, Hosseinipour MC; HPTN 084 study group. Delany-Moretlwe S, et al. Among authors: hendrix cw. Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1. Lancet. 2022. PMID: 35378077 Free PMC article. Clinical Trial.
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial.
Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, Anderson PL, Hendrix CW, Adeyeye A, Rooney JF, Rinehart AR, Cohen MS, McCauley M, Grinsztejn B; HPTN 083 Study Team. Landovitz RJ, et al. Among authors: hendrix cw. Lancet HIV. 2023 Dec;10(12):e767-e778. doi: 10.1016/S2352-3018(23)00261-8. Epub 2023 Nov 9. Lancet HIV. 2023. PMID: 37952550 Free PMC article. Clinical Trial.
In Response.
Dalesio NM, Lee CKK, Hendrix CW. Dalesio NM, et al. Among authors: hendrix cw. Anesth Analg. 2022 Feb 1;134(2):e8-e9. doi: 10.1213/ANE.0000000000005814. Anesth Analg. 2022. PMID: 35030130 No abstract available.
In Response.
Dalesio NM, Lee CKK, Hendrix CW. Dalesio NM, et al. Among authors: hendrix cw. Anesth Analg. 2017 Jul;125(1):362-363. doi: 10.1213/ANE.0000000000002177. Anesth Analg. 2017. PMID: 28617700 No abstract available.
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084.
Marzinke MA, Han K, Hanscom B, Guo X, Piwowar-Manning E, Hendrix CW, Rose S, Spooner E, Mathew C, Innes S, Sekabira R, Mutambanengwe M, Rooney JF, Rinehart AR, Adeyeye A, Cohen MS, Hosseinipour M, Ford SL, Delany-Moretlwe S. Marzinke MA, et al. Among authors: hendrix cw. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0099424. doi: 10.1128/aac.00994-24. Epub 2024 Sep 23. Antimicrob Agents Chemother. 2024. PMID: 39311597 Free PMC article. Clinical Trial.
Topical Microbicides in HIV Prevention: State of the Promise.
Baeten JM, Hendrix CW, Hillier SL. Baeten JM, et al. Among authors: hendrix cw. Annu Rev Med. 2020 Jan 27;71:361-377. doi: 10.1146/annurev-med-090518-093731. Epub 2019 Oct 15. Annu Rev Med. 2020. PMID: 31613684 Free PMC article. Review.
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.
Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Delany-Moretlwe S, et al. Among authors: hendrix cw. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. J Int AIDS Soc. 2025. PMID: 39748218 Free PMC article. Clinical Trial.
Safety data needed for concurrent use of ARV-based PrEP.
Dunbar MS, Rodrigues J, Chatani M, Baeten JM, Hendrix CW, Palanee-Phillips T, van der Straten A, Mgodi N, Brown E, Makura C, Namwanje S, Torjesen K. Dunbar MS, et al. Among authors: hendrix cw. Lancet HIV. 2022 Nov;9(11):e742-e744. doi: 10.1016/S2352-3018(22)00256-9. Epub 2022 Sep 27. Lancet HIV. 2022. PMID: 36179732 No abstract available.
285 results